e-learning
resources
Madrid 2019
Monday, 30.09.2019
Cardiovascular comorbidities in COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Value of peak oxygen pulse for detection of cardiac comorbidities in patients with chronic obstructive pulmonary disease
S. Keymel (Duesseldorf, Germany), D. Weber (Duesseldorf, Germany), R. Orzech (Duesseldorf, Germany), S. Krüger (Duesseldorf, Germany)
Source:
International Congress 2019 – Cardiovascular comorbidities in COPD
Session:
Cardiovascular comorbidities in COPD
Session type:
Thematic Poster
Number:
2669
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Keymel (Duesseldorf, Germany), D. Weber (Duesseldorf, Germany), R. Orzech (Duesseldorf, Germany), S. Krüger (Duesseldorf, Germany). Value of peak oxygen pulse for detection of cardiac comorbidities in patients with chronic obstructive pulmonary disease. 2669
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Should all chronic obstructive pulmonary disease (COPD) patients with cardiac co-morbidities have ambulatory oxygen assessment?
Source: Annual Congress 2008 - Exercise: system responses
Year: 2008
Predictors of exercise-induced oxygen desaturation in subjects with chronic obstructive pulmonary disease
Source: International Congress 2018 – Chronic respiratory disease: effects of rehabilitation interventions in patients
Year: 2018
Exercise heart rate recovery in chronic obstructive pulmonary disease patients
Source: Annual Congress 2010 - Exercise in COPD
Year: 2010
Frequency of adverse consequences after spirography in patients with chronic obstructive pulmonary disease and concomitant ischemic heart disease
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
Blood pressure and heart rate variability response to noninvasive ventilation in patients with exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2007 - Clinical applications of noninvasive ventilation
Year: 2007
Echocardiographic measurements in hypoxemic COPD patients receiving long-term oxygen therapy
Source: Annual Congress 2005 - COPD - pulmonary haemodynamics and gas exchange
Year: 2005
Noninvasive positive pressure ventilation in patients with acute exacerbations of chronic obstructive pulmonary disease patients with acute respiratory failure
Source: Eur Respir J 2005; 26: Suppl. 49, 549s
Year: 2005
The heart rate variability in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2008 - COPD
Year: 2008
Effect of noninvasive ventilation on exercise performance in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2007; 30: Suppl. 51, 129s
Year: 2007
Nasal high flow versus Non-invasive ventilation in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2019 – Treatment of acute respiratory failure with noninvasive ventilation
Year: 2019
Stroke volume augmentation during exercise in patients with chronic obstructive pulmonary disease with and without pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary vascular diseases
Year: 2010
Oxygen uptake efficiency slope in chronic heart failure and chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Exercise: system responses
Year: 2008
Mechanisms of ECG changes in chronic obstructive pulmonary disease
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016
Respiratory event hospitalizations are reduced in heart failure patients with comorbid chronic obstructive pulmonary disease using a wireless implanted pulmonary artery pressure monitoring system
Source: Annual Congress 2012 - Pulmonary circulation: end-points and biomarkers
Year: 2012
Non-invasive ventilation in acute respiratory failure in a pulmonary ward: chronic obstructive pulmonary disease versus other indications
Source: International Congress 2018 – Non-invasive ventilation for acute respiratory failure
Year: 2018
Are acute changes in CO2 measurable with transcutaneous technique in patients with very severe chronic obstructive pulmonary disease?
Source: International Congress 2015 – COPD: notable points
Year: 2015
Oxygen therapy in chronic obstructive pulmonary disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=302
Year: 2006
Use of spirometry screening for patients with chronic obstructive pulmonary disease (COPD) requiring oxygen therapy
Source: Eur Respir J 2006; 28: Suppl. 50, 838s
Year: 2006
The frequency of the cardiac arrhythmias of the patients who suffer from the chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 26: Suppl. 49, 509s
Year: 2005
Association of phase angle and hypoxemia in ambulatory patients with chronic obstructive pulmonary disease and heart failure.
Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept